Gp96SIVIg immunization induces potent polyepitope specific, multifunctional memory responses in rectal and vaginal mucosa

Vaccine

Volumn 29, Issue 14, 2011, Pages 2619-2625

  Strbo, Natasa ^a   Vaccari, Monica ^b   Pahwa, Savita ^a   Kolber, Michael A ^a   Fisher, Eva ^a   Gonzalez, Louis ^a   Doster, Melvin N ^b   Hryniewicz, Anna ^b   Felber, Barbara K ^c   Pavlakis, George N ^c   Franchini, Genoveffa ^b   Podack, Eckhard R ^a  

^a UNIVERSITY OF MIAMI MILLER SCHOOL OF MEDICINE   (United States)

^b NATIONAL CANCER INSTITUTE   (United States)

^c NATIONAL CANCER INSTITUTE   (United States)

Author keywords

Gp96 chaperone; Mucosa; Non human primate; Rectum; Vagina

Indexed keywords

CD103 ANTIGEN; CHAPERONE; COMPLEMENTARY DNA; CYTOKINE; GAG PROTEIN; GAMMA INTERFERON; GRANZYME B; HEAT SHOCK PROTEIN; HEAT SHOCK PROTEIN GP96 IG; HYBRID PROTEIN; INTERLEUKIN 2; NEF PROTEIN; REV PROTEIN; SIMIAN IMMUNODEFICIENCY VIRUS VACCINE; TETRAMER; TRANSACTIVATOR PROTEIN; UNCLASSIFIED DRUG; VIRUS ANTIGEN; VIRUS ENVELOPE PROTEIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIGEN EXPRESSION; ANTIGEN SPECIFICITY; ARTICLE; CD8+ T LYMPHOCYTE; CELL EXPANSION; CELL MIGRATION; CONTROLLED STUDY; CROSS PRESENTATION; CYTOKINE RELEASE; CYTOTOXIC T LYMPHOCYTE; DRUG SENSITIVITY; FEMALE; IMMUNIZATION; MACACA; MEMORY T LYMPHOCYTE; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; PROTEIN EXPRESSION; RECTUM MUCOSA; SIMIAN IMMUNODEFICIENCY VIRUS; VAGINA MUCOSA; WESTERN BLOTTING;

ANIMALS; CD4-POSITIVE T-LYMPHOCYTES; CD8-POSITIVE T-LYMPHOCYTES; CYTOKINES; EPITOPES; FEMALE; IMMUNITY, MUCOSAL; IMMUNIZATION; IMMUNIZATION, SECONDARY; IMMUNOLOGIC MEMORY; MACACA MULATTA; MEMBRANE GLYCOPROTEINS; RECTUM; SAIDS VACCINES; T-LYMPHOCYTES, CYTOTOXIC; VAGINA;

EID: 79952248385     PISSN: 0264410X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.vaccine.2011.01.044     Document Type: Article

References (37)

1. Li Z., Srivastava P.K. Tumor rejection antigen gp96/grp94 is an ATPase: implications for protein folding and antigen presentation. EMBO J 1993, 12(August (8)):3143-3151.
2. Srivastava P.K., Kozak C.A., Old L.J. Chromosomal assignment of the gene encoding the mouse tumor rejection antigen gp96. Immunogenetics 1988, 28(3):205-207.
3. Arnold-Schild D., Hanau D., Spehner D., Schmid C., Rammensee H.G., de la Salle H., et al. Cutting edge: receptor-mediated endocytosis of heat shock proteins by professional antigen-presenting cells. J Immunol 1999, 162(April (7)):3757-3760.
4. Binder R.J., Han D.K., Srivastava P.K. CD91: a receptor for heat shock protein gp96. Nat Immunol 2000, 1(August (2)):151-155.
5. Binder R.J., Srivastava P.K. Peptides chaperoned by heat-shock proteins are a necessary and sufficient source of antigen in the cross-priming of CD8+ T cells. Nat Immunol 2005, 6(June (6)):593-599.
6. Singh-Jasuja H., Hilf N., Arnold-Schild D., Schild H. The role of heat shock proteins and their receptors in the activation of the immune system. Biol Chem 2001, 382(April (4)):629-636.
7. Srivastava P.K. Peptide-binding heat shock proteins in the endoplasmic reticulum: role in immune response to cancer and in antigen presentation. Adv Cancer Res 1993, 62:153-177.
8. Yamazaki K., Nguyen T., Podack E.R. Cutting edge: tumor secreted heat shock-fusion protein elicits CD8 cells for rejection. J Immunol 1999, 163(November (10)):5178-5182.
9. Oizumi S., Deyev V., Yamazaki K., Schreiber T., Strbo N., Rosenblatt J., et al. Surmounting tumor-induced immune suppression by frequent vaccination or immunization in the absence of B cells. J Immunother 2008, 31(May (4)):394-401.
10. Schreiber T.H., Deyev V.V., Rosenblatt J.D., Podack E.R. Tumor-induced suppression of CTL expansion and subjugation by gp96-Ig vaccination. Cancer Res 2009, 69(March (5)):2026-2033.
11. Oizumi S., Strbo N., Pahwa S., Deyev V., Podack E.R. Molecular and cellular requirements for enhanced antigen cross-presentation to CD8 cytotoxic T lymphocytes. J Immunol 2007, 179(August (4)):2310-2317.
12. Blachere N.E., Li Z., Chandawarkar R.Y., Suto R., Jaikaria N.S., Basu S., et al. Heat shock protein-peptide complexes, reconstituted in vitro, elicit peptide-specific cytotoxic T lymphocyte response and tumor immunity. J Exp Med 1997, 186(October (8)):1315-1322.
13. Schneider R., Campbell M., Nasioulas G., Felber B.K., Pavlakis G.N. Inactivation of the human immunodeficiency virus type 1 inhibitory elements allows Rev-independent expression of Gag and Gag/protease and particle formation. J Virol 1997, 71(July (7)):4892-4903.
14. Hel Z., Johnson J.M., Tryniszewska E., Tsai W.P., Harrod R., Fullen J., et al. A novel chimeric Rev, Tat, and Nef (Retanef) antigen as a component of an SIV/HIV vaccine. Vaccine 2002, 20(August (25-26)):3171-3186.
15. von Gegerfelt A., Felber B.K. Replacement of posttranscriptional regulation in SIVmac239 generated a Rev-independent infectious virus able to propagate in rhesus peripheral blood mononuclear cells. Virology 1997, 232(June (2)):291-299.
16. Strbo N., Pahwa S., Kolber M.A., Gonzalez L., Fisher E., Podack E.R. Cell-secreted Gp96-Ig-peptide complexes induce lamina propria and intraepithelial CD8+ cytotoxic T lymphocytes in the intestinal mucosa. Mucosal Immunol 2010, 3(March (2)):182-192.
17. Raez L.E., Cassileth P.A., Schlesselman J.J., Padmanabhan S., Fisher E.Z., Baldie P.A., et al. Induction of CD8 T-cell-Ifn-gamma response and positive clinical outcome after immunization with gene-modified allogeneic tumor cells in advanced non-small-cell lung carcinoma. Cancer Gene Ther 2003, 10(November (11)):850-858.
18. Raez L.E., Cassileth P.A., Schlesselman J.J., Sridhar K., Padmanabhan S., Fisher E.Z., et al. Allogeneic vaccination with a B7.1 HLA-A gene-modified adenocarcinoma cell line in patients with advanced non-small-cell lung cancer. J Clin Oncol 2004, 22(July (14)):2800-2807.
19. Srivastava P.K., DeLeo A.B., Old L.J. Tumor rejection antigens of chemically induced sarcomas of inbred mice. Proc Natl Acad Sci USA 1986, 83(May (10)):3407-3411.
20. Chandawarkar R.Y., Wagh M.S., Srivastava P.K. The dual nature of specific immunological activity of tumor-derived gp96 preparations. J Exp Med 1999, 189(May (9)):1437-1442.
21. Matsutake T., Sawamura T., Srivastava P.K. High efficiency CD91- and LOX-1-mediated re-presentation of gp96-chaperoned peptides by MHC II molecules. Cancer Immun 2010, 10:7.
22. Pitcher C.J., Hagen S.I., Walker J.M., Lum R., Mitchell B.L., Maino V.C., et al. Development and homeostasis of T cell memory in rhesus macaque. J Immunol 2002, 168(January (1)):29-43.
23. Cicin-Sain L., Messaoudi I., Park B., Currier N., Planer S., Fischer M., et al. Dramatic increase in naive T cell turnover is linked to loss of naive T cells from old primates. Proc Natl Acad Sci USA 2007, 104(December (50)):19960-19965.
24. Jankovic V., Messaoudi I., Nikolich-Zugich J. Phenotypic and functional T-cell aging in rhesus macaques (Macaca mulatta): differential behavior of CD4 and CD8 subsets. Blood 2003, 102(November (9)):3244-3251.
25. Vaccari M., Trindade C.J., Venzon D., Zanetti M., Franchini G. Vaccine-induced CD8+ central memory T cells in protection from simian AIDS. J Immunol 2005, 175(September (6)):3502-3507.
26. Masopust D. Developing an HIV cytotoxic T-lymphocyte vaccine: issues of CD8 T-cell quantity, quality and location. J Intern Med 2009, 265(January (1)):125-137.
27. Li Q., Skinner P.J., Ha S.J., Duan L., Mattila T.L., Hage A., et al. Visualizing antigen-specific and infected cells in situ predicts outcomes in early viral infection. Science 2009, 323(March (5922)):1726-1729.
28. Kaech S.M., Tan J.T., Wherry E.J., Konieczny B.T., Surh C.D., Ahmed R. Selective expression of the interleukin 7 receptor identifies effector CD8 T cells that give rise to long-lived memory cells. Nat Immunol 2003, 4(December (12)):1191-1198.
29. Belyakov I.M., Derby M.A., Ahlers J.D., Kelsall B.L., Earl P., Moss B., et al. Mucosal immunization with HIV-1 peptide vaccine induces mucosal and systemic cytotoxic T lymphocytes and protective immunity in mice against intrarectal recombinant HIV-vaccinia challenge. Proc Natl Acad Sci USA 1998, 95(February (4)):1709-1714.
30. Belyakov I.M., Hammond S.A., Ahlers J.D., Glenn G.M., Berzofsky J.A. Transcutaneous immunization induces mucosal CTLs and protective immunity by migration of primed skin dendritic cells. J Clin Invest 2004, 113(April (7)):998-1007.
31. Rangel-Moreno J., Moyron-Quiroz J.E., Carragher D.M., Kusser K., Hartson L., Moquin A., et al. Omental milky spots develop in the absence of lymphoid tissue-inducer cells and support B and T cell responses to peritoneal antigens. Immunity 2009, 30(May (5)):731-743.
32. Carlow D.A., Gold M.R., Ziltener H.J. Lymphocytes in the peritoneum home to the omentum and are activated by resident dendritic cells. J Immunol 2009, 183(July (2)):1155-1165.
33. Bedoui S., Whitney P.G., Waithman J., Eidsmo L., Wakim L., Caminschi I., et al. Cross-presentation of viral and self antigens by skin-derived CD103+ dendritic cells. Nat Immunol 2009, 10(May (5)):488-495.
34. Kunkel E.J., Campbell J.J., Haraldsen G., Pan J., Boisvert J., Roberts A.I., et al. Lymphocyte CC chemokine receptor 9 and epithelial thymus-expressed chemokine (TECK) expression distinguish the small intestinal immune compartment: epithelial expression of tissue-specific chemokines as an organizing principle in regional immunity. J Exp Med 2000, 192(September (5)):761-768.
35. Stenstad H., Svensson M., Cucak H., Kotarsky K., Agace W.W. Differential homing mechanisms regulate regionalized effector CD8alphabeta+ T cell accumulation within the small intestine. Proc Natl Acad Sci USA 2007, 104(June (24)):10122-10127.
36. Annunziato F., Cosmi L., Liotta F., Lazzeri E., Romagnani P., Angeli R., et al. CXCR3 and alphaEbeta7 integrin identify a subset of CD8+ mature thymocytes that share phenotypic and functional properties with CD8+ gut intraepithelial lymphocytes. Gut 2006, 55(July (7)):961-968.
37. Oyama T., Miura S., Watanabe C., Hokari R., Fujiyama Y., Komoto S., et al. CXCL12 and CCL20 play a significant role in mucosal T-lymphocyte adherence to intestinal microvessels in mice. Microcirculation 2007, 14(September-October (7)):753-766.